Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age over 18 years old~* low back pain for more than 3 months~* Modic type I or II change in lumbar magnetic resonance imaging~* Intensity of low back pain at least 6 on 10-cm VAS or Oswestry disability score at least 30%~Exclusion Criteria:~* premenopausal female patients with possibility of pregnancy~* patients with calculated creatinine clearance of less than 40 ml/min~* patients with hypocalcemia~* patients with known hypersensitivity to zoledronic acid or other bisphosphonates or ingredients of the infusional product~* patients with red flags symptoms~* patients with nerve root impingement~* patients with willingness for early retirement

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Zoledronic acid (Type: ACTIVE_COMPARATOR): Single infusion of 5 mg zoledronic acid I.V.
- Placebo (Type: PLACEBO_COMPARATOR): Single infusion of 100 ml isotonic NaCl-solution I.V.

Based on this trial design, predict the completion outcome and termination type (if applicable).